ENGOT-ov65/KEYNOTE-B96: Phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer

Simple item page
dc.contributor.authorColombo, Nicoletta
dc.contributor.authorColeman, Robert L.
dc.contributor.authorWu, Xiaohua
dc.contributor.authorKose, Fatih
dc.contributor.authorWenham, Robert Michael
dc.contributor.authorSebastianelli, Alexandra
dc.contributor.authorHasegawa, Kosei
dc.contributor.authorZsiros, Emese
dc.contributor.authorRouge, Thibault De la Motte
dc.contributor.authorBidzinski, Mariusz
dc.contributor.authorMcNeish, Iain A.
dc.contributor.authorSehouli, Jalid
dc.contributor.authorKorach, Jacob
dc.contributor.authorDebruyne, Philip R.
dc.contributor.authorKim, Jae-Weon
dc.contributor.authorDe Melo, Andrea C.
dc.contributor.authorPeng, Xuan
dc.contributor.authorBogusz, Agata M.
dc.contributor.authorYamada, Karin Sayuri
dc.contributor.authorMonk, Bradley J.
dc.date.accessioned2022-11-04T11:30:39Z
dc.date.available2022-11-04T11:30:39Z
dc.date.issued2022
dc.identifier.issn0732-183Xen_US
dc.identifier.issue16en_US
dc.identifier.urihttp://hdl.handle.net/11727/8008
dc.identifier.volume40en_US
dc.identifier.wos000863680305016en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleENGOT-ov65/KEYNOTE-B96: Phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian canceren_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar